Related Experiment Video

Updated: Apr 5, 2026

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma
07:01

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma

Published on: April 17, 2013

21.8K

New agent to treat advanced or metastasized thyroid cancer, its efficacy, safety, and mechanism

Huan-Gao Zhu1, Jun-Yu Zhao2, Rui Zhang2

  • 1Division of Endocrinology, Department of Internal Medicine, Qilu Hospital of Shandong University Jinan, China.

Thoracic Cancer
|August 15, 2015
PubMed
Abstract

Insights

Vandetanib significantly improves progression-free survival (PFS) in advanced thyroid cancer patients. This targeted therapy offers a promising treatment option despite potential side effects like rash and diarrhea.

Area of Science:

  • Oncology
  • Pharmacology

Background:

  • Vandetanib is the first FDA-approved drug for advanced or metastasized thyroid cancer.
  • Understanding its efficacy and safety is crucial for clinical application.

Purpose of the Study:

  • To systematically review the efficacy and safety of Vandetanib in thyroid cancer patients.
  • To assess its impact on progression-free survival (PFS) and adverse events.

Main Methods:

  • Systematic literature review of trial data from multiple databases (PubMed, EMBASE, Medline, CNKI, Cochrane).
  • No language restrictions were applied during data retrieval.
  • Assessment of median PFS and adverse events associated with Vandetanib therapy.

Main Results:

  • Vandetanib significantly prolonged PFS compared to placebo (30.5 vs. 19.3 months, HR 0.46).
  • PFS was also extended in patients with surgically unresectable or metastatic differentiated thyroid cancer (11.1 vs. 5.9 months, HR 0.63).
  • Common side effects included rash, diarrhea, neutropenia, and hypertension.

Conclusions:

  • Vandetanib demonstrates a significant improvement in PFS for advanced thyroid cancer.
  • It is a promising therapeutic agent, particularly for metastasized or advanced medullary thyroid carcinoma, despite notable side effects.
Keywords:
Randomized controlled trialthyroid cancervandetinib

More Related Videos

Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma06:08

Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma

Published on: June 2, 2023

2.6K
Spontaneous Murine Model of Anaplastic Thyroid Cancer05:39

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

2.4K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
9.1K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
69
Functions of Thyroid Hormones01:18

Functions of Thyroid Hormones

The thyroid hormone (TH) plays a pivotal role in the intricate orchestration of physiological processes, exerting profound effects on development, metabolism, and homeostasis throughout different life stages.
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
6.7K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.4K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.3K